Kissei Pharmaceutical logo

Kissei Pharmaceutical

Asia, Nagano, Japan, Matsumoto

Description

Kissei Pharmaceutical is a food company.

Investor Profile

Kissei Pharmaceutical has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 100% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Health Diagnostics.

Stage Focus

  • Series D (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Health Diagnostics
  • Oncology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kissei Pharmaceutical frequently co-invest with?

PC
North America, California, United States, Los Angeles
Co-Investments: 1
Camford Capital
North America, California, United States, Palo Alto
Co-Investments: 1
ORI Capital
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1

What are some of recent deals done by Kissei Pharmaceutical?

CG Oncology

Irvine, California, United States

CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

BiotechnologyHealth CareHealth DiagnosticsOncology
Series DDec 10, 2020
Amount Raised: $47,000,000